共 50 条
- [41] A phase I, first-in-human, safety, pharmacokinetic, and pharmacodynamic study of oral dubermatinib (TP-0903) in patients with advanced solid tumoursANNALS OF ONCOLOGY, 2020, 31 : S469 - S469Adjei, A. A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Oncol Dept, Rochester, MN USA Mayo Clin, Oncol Dept, Rochester, MN USABeg, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Southwestern Med Ctr Dallas, Hematol & Med Oncol, Dallas, TX 75390 USA Mayo Clin, Oncol Dept, Rochester, MN USAMelear, J.论文数: 0 引用数: 0 h-index: 0机构: Texas Oncol Austin Midtown, Hematol Oncol, Austin, TX USA Mayo Clin, Oncol Dept, Rochester, MN USAThompson, J.论文数: 0 引用数: 0 h-index: 0机构: Med Coll Wisconsin, Canc Ctr, Froedtert Hosp, Milwaukee, WI 53226 USA Mayo Clin, Oncol Dept, Rochester, MN USATsai, F. Y-C.论文数: 0 引用数: 0 h-index: 0机构: Virginia G Piper Canc Ctr Clin Trials, Hematol Oncol, Scottsdale, AZ USA Mayo Clin, Oncol Dept, Rochester, MN USABaranda, J. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas Med Ctr KUMC, Med Oncol Dept, Kansas City, KS USA Mayo Clin, Oncol Dept, Rochester, MN USABastos, B.论文数: 0 引用数: 0 h-index: 0机构: Miami Canc Inst, Radiat Oncol, Miami, FL USA Mayo Clin, Oncol Dept, Rochester, MN USASpira, A.论文数: 0 引用数: 0 h-index: 0机构: Virginia Canc Specialist, Res Inst, Fairfax, VA USA Mayo Clin, Oncol Dept, Rochester, MN USALou, Y.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Oncol, Jacksonville, FL 32224 USA Mayo Clin, Oncol Dept, Rochester, MN USASeetharam, M.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Oncol, Phoenix, AZ USA Mayo Clin, Oncol Dept, Rochester, MN USAUemura, M.论文数: 0 引用数: 0 h-index: 0机构: Willamette Valley Canc Inst, Country Club, Eugene, OR USA Mayo Clin, Oncol Dept, Rochester, MN USACamidge, D. R.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado, Med Oncol, Ctr Canc, Aurora, CO USA Mayo Clin, Oncol Dept, Rochester, MN USAYamamoto, N.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Dev Therapeut, Tokyo, Japan Mayo Clin, Oncol Dept, Rochester, MN USACowey, C. L.论文数: 0 引用数: 0 h-index: 0机构: Texas Oncol, Baylor Sammons Canc Ctr, Dallas, TX USA Mayo Clin, Oncol Dept, Rochester, MN USADoi, T.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Expt Therapeut Dept, Kashiwa, Chiba, Japan Mayo Clin, Oncol Dept, Rochester, MN USAAnthony, S. P.论文数: 0 引用数: 0 h-index: 0机构: Tolero Pharmaceut Inc, Clin Res, Lehi, UT USA Mayo Clin, Oncol Dept, Rochester, MN USAJanat-Amsbury, M.论文数: 0 引用数: 0 h-index: 0机构: Tolero Pharmaceut Inc, Clin Trials Clin Res, Lehi, UT USA Mayo Clin, Oncol Dept, Rochester, MN USAWade, M.论文数: 0 引用数: 0 h-index: 0机构: Tolero Pharmaceut Inc, Res, Lehi, UT USA Mayo Clin, Oncol Dept, Rochester, MN USABearss, D. J.论文数: 0 引用数: 0 h-index: 0机构: Tolero Pharmaceut Inc, Off CEO, Lehi, UT USA Mayo Clin, Oncol Dept, Rochester, MN USASarantopoulos, J.论文数: 0 引用数: 0 h-index: 0机构: Inst Drug Dev Canc Therapy Res Ctr, Therapy Res Ctr, San Antonio, TX USA Mayo Clin, Oncol Dept, Rochester, MN USA
- [42] Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumoursBRITISH JOURNAL OF CANCER, 2011, 104 (05) : 756 - 762Razak, A. R. A.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, Canada Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaHotte, S. J.论文数: 0 引用数: 0 h-index: 0机构: Juravinski Canc Ctr, Dept Haematol & Med Oncol, Hamilton, ON L8V 5C2, Canada Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaSiu, L. L.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, Canada Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaChen, E. X.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, Canada Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaHirte, H. W.论文数: 0 引用数: 0 h-index: 0机构: Juravinski Canc Ctr, Dept Haematol & Med Oncol, Hamilton, ON L8V 5C2, Canada Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaPowers, J.论文数: 0 引用数: 0 h-index: 0机构: Queens Univ, Canc Res Inst, Canc Clin Trials Div, NCIC Clin Trials Grp NCIC CTG, Kingston, ON K7L 3N6, Canada Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaWalsh, W.论文数: 0 引用数: 0 h-index: 0机构: Queens Univ, Canc Res Inst, Canc Clin Trials Div, NCIC Clin Trials Grp NCIC CTG, Kingston, ON K7L 3N6, Canada Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaStayner, L-A论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, Canada Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaLaughlin, A.论文数: 0 引用数: 0 h-index: 0机构: Juravinski Canc Ctr, Dept Haematol & Med Oncol, Hamilton, ON L8V 5C2, Canada Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaNovotny-Diermayr, V.论文数: 0 引用数: 0 h-index: 0机构: S BIO Pte Ltd, Singapore 117528, Singapore Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaZhu, J.论文数: 0 引用数: 0 h-index: 0机构: S BIO Pte Ltd, Singapore 117528, Singapore Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, CanadaEisenhauer, E. A.论文数: 0 引用数: 0 h-index: 0机构: S BIO Pte Ltd, Singapore 117528, Singapore Princess Margaret Hosp, Dept Med Oncol & Haematol, Drug Dev Program, Toronto, ON M5G 2M9, Canada
- [43] Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumoursBRITISH JOURNAL OF CANCER, 2004, 91 (09) : 1651 - 1655Harries, M论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, CRUK Dept Med Oncol, Sutton SM2 5PT, Surrey, EnglandO'Donnell, A论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, CRUK Dept Med Oncol, Sutton SM2 5PT, Surrey, EnglandScurr, M论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, CRUK Dept Med Oncol, Sutton SM2 5PT, Surrey, EnglandReade, S论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, CRUK Dept Med Oncol, Sutton SM2 5PT, Surrey, EnglandCole, C论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, CRUK Dept Med Oncol, Sutton SM2 5PT, Surrey, EnglandJudson, I论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, CRUK Dept Med Oncol, Sutton SM2 5PT, Surrey, EnglandGreystoke, A论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, CRUK Dept Med Oncol, Sutton SM2 5PT, Surrey, EnglandTwelves, C论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, CRUK Dept Med Oncol, Sutton SM2 5PT, Surrey, EnglandKaye, S论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Inst Canc Res, CRUK Dept Med Oncol, Sutton SM2 5PT, Surrey, England
- [44] A phase I/II study of DHP107, a novel oral paclitaxel formulation, in patients with advanced solid tumors (phase I) and gastric cancer (phase II).JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)Ryu, Min-Hee论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaRyoo, Baek-Yeol论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaKim, Tae Won论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaKim, Sung-Bae论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaLim, Hyeong-Seok论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaBae, Kyun-Seop论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaPark, Sook Ryun论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaJo, Yeong-Woo论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaCho, Hyun Ju论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaKang, Yoon-Koo论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
- [45] Phase I and Pharmacokinetic Study of Sequential Paclitaxel and Trabectedin Every 2 Weeks in Patients with Advanced Solid TumorsCLINICAL CANCER RESEARCH, 2010, 16 (09) : 2656 - 2665Chu, Quincy论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAMita, Alain论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAForouzesh, Bahram论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USATolcher, Anthony W.论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USASchwartz, Gary论文数: 0 引用数: 0 h-index: 0机构: Brooke Army Med Ctr, San Antonio, TX USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USANieto, Antonio论文数: 0 引用数: 0 h-index: 0机构: PharmaMar Clin R&D, Madrid, Spain Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USASoto-Matos, Arturo论文数: 0 引用数: 0 h-index: 0机构: PharmaMar Clin R&D, Madrid, Spain Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAAlfaro, Vicente论文数: 0 引用数: 0 h-index: 0机构: PharmaMar Clin R&D, Madrid, Spain Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USALebedinsky, Claudia论文数: 0 引用数: 0 h-index: 0机构: PharmaMar Clin R&D, Madrid, Spain Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USARowinsky, Eric K.论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA
- [46] A PHARMACOKINETIC STUDY OF ORAL PACLITAXEL IN COMBINATION WITH HM30181 IN SOLID CANCER PATIENTSCLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S36 - S36Kim, S. E.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South KoreaGu, N.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South KoreaShin, D.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South KoreaYoon, S. H.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South KoreaCho, J. Y.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South KoreaShin, S. G.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South KoreaYu, K. S.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South KoreaJang, I. J.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
- [47] Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid TumoursAdvances in Therapy, 2018, 35 : 1945 - 1964Ruth Plummer论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamHenk M. Verheul论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamFilip Y. F. L. De Vos论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamKarin Leunen论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamL. Rhoda Molife论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamChristian Rolfo论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamPeter Grundtvig-Sørensen论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamJacques De Grève论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamSylvie Rottey论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamGuy Jerusalem论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamAntoine Italiano论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamJames Spicer论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamLuc Dirix论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamCarsten Goessl论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamJoseph Birkett论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamStuart Spencer论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamMaria Learoyd论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamChristopher Bailey论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center AmsterdamEmma Dean论文数: 0 引用数: 0 h-index: 0机构: Northern Centre for Cancer Care,Department of Medical Oncology, Cancer Center Amsterdam
- [48] Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid TumoursADVANCES IN THERAPY, 2018, 35 (11) : 1945 - 1964Plummer, Ruth论文数: 0 引用数: 0 h-index: 0机构: Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandVerheul, Henk M.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandDe Vos, Filip Y. F. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Utrecht, Univ Med Ctr Utrecht, Utrecht, Netherlands Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandLeunen, Karin论文数: 0 引用数: 0 h-index: 0机构: Univ Ziekenhuis Leuven, Leuven, Belgium Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandMolife, L. Rhoda论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden & Inst Canc Res, Sutton, Surrey, England Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandRolfo, Christian论文数: 0 引用数: 0 h-index: 0机构: Univ Ziekenhuis Antwerpen, Antwerp, Belgium Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandGrundtvig-Sorensen, Peter论文数: 0 引用数: 0 h-index: 0机构: Univ Copenhagen, Herlev Hosp, Herlev, Denmark Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandDe Greve, Jacques论文数: 0 引用数: 0 h-index: 0机构: Univ Ziekenhuis Brussel, Oncol Ctr, Dept Med Oncol, Brussels, Belgium Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandRottey, Sylvie论文数: 0 引用数: 0 h-index: 0机构: Univ Ziekenhuis Gent, Ghent, Belgium Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandJerusalem, Guy论文数: 0 引用数: 0 h-index: 0机构: Univ Liege, CHU Sart Tilman Liege, Liege, Belgium Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandItaliano, Antoine论文数: 0 引用数: 0 h-index: 0机构: Comprehens Canc Ctr Bordeaux, Inst Bergonie, Dept Med Oncol, Bordeaux, France Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandSpicer, James论文数: 0 引用数: 0 h-index: 0机构: Kings Coll London, Guys Hosp, London, England Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandDirix, Luc论文数: 0 引用数: 0 h-index: 0机构: GZA Ziekenhuizen, Campus Sint Augustinus, Antwerp, Belgium Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandGoessl, Carsten论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gaithersburg, MD USA Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandBirkett, Joseph论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandSpencer, Stuart论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandLearoyd, Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandBailey, Christopher论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, EnglandDean, Emma论文数: 0 引用数: 0 h-index: 0机构: Univ Manchester, Christie NHS Fdn Trust, Manchester, Lancs, England Newcastle Univ, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England
- [49] Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumoursEUROPEAN JOURNAL OF CANCER, 2011, 47 (09) : 1328 - 1335de Jonge, M. J. A.论文数: 0 引用数: 0 h-index: 0机构: Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, NetherlandsDumez, H.论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Louvain, Leuven Canc Inst, Univ Hosp Leuven, Dept Gen Med Oncol, B-3000 Louvain, Belgium Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, NetherlandsKitzen, J. J. E. M.论文数: 0 引用数: 0 h-index: 0机构: Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, NetherlandsBeuselinck, B.论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Louvain, Leuven Canc Inst, Univ Hosp Leuven, Dept Gen Med Oncol, B-3000 Louvain, Belgium Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, NetherlandsVerweij, J.论文数: 0 引用数: 0 h-index: 0机构: Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, NetherlandsCourtney, R.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, La Jolla, CA USA Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, NetherlandsBattista, A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Milan, Italy Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, NetherlandsBrega, N.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Milan, Italy Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, NetherlandsSchoffski, R.论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Louvain, Leuven Canc Inst, Univ Hosp Leuven, Dept Gen Med Oncol, B-3000 Louvain, Belgium Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands
- [50] Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumoursEUROPEAN JOURNAL OF CANCER, 2002, 38 (18) : 2407 - 2415de Jonge, MJA论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, Netherlands Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsVerweij, J论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, Netherlandsvan der Gaast, A论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsValota, O论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsMora, O论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsPlanting, AST论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsMantel, MA论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsVan den Bosch, S论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsLechuga, MJ论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsFiorentini, F论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsHess, D论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, NetherlandsSessa, C论文数: 0 引用数: 0 h-index: 0机构: Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, NL-3705 EA Rotterdam, Netherlands